Thursday, November 22, 2007

Micromet, Inc. Elects Joseph P. Slattery To Board Of Directors

ABN Newswire - neutralizing the activity of granulocyte/macrophage colony stimulating factor (GM-CSF), which has potential applications in the treatment of various inflammatory and autoimmune diseases, such as rheumatoid arthritis, psoriasis, or Read More

0 comments: